César de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania, where he leads the Machine Biology group to integrate synthetic biology, microbiology and artificial intelligence.

His group aims to develop computer-made tools and medicines to replenish our current antibiotic arsenal. César is a National Institutes of Health (NIH) Maximizing Investigator’s Research Award investigator, a BBRF Young Investigator, and has received recognition and research funding from numerous other groups.

César was also recognized by MIT Technology Review in 2019 as one of the world’s top innovators for “digitizing evolution to make better antibiotics” and was the inaugural recipient of the Langer Prize in 2019 and received the ACS Infectious Diseases Young Investigator Award in 2020. He has also been named a 2018 Wunderkind by STAT News, a Top 10 Under 40 of 2019 by GEN and as one of the 30 Rising Leaders in the Life Sciences.

César has published over 75 peer-reviewed publications and secured multiple patents.